These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14094498)

  • 1. [CLINICAL EVALUATION OF A NEW ANTI-ULCER PRODUCT (GERANYL FARNESYLACETATE)].
    BERTERO R; SARACCO C; BRUNO G
    Minerva Gastroenterol; 1963; 9():158-65. PubMed ID: 14094498
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE TREATMENT OF GASTRODUODENAL ULCER AND OF GASTRODUODENITIS WITH GERANYL FARNESYLACETATE].
    CASTELLETTA L
    Minerva Gastroenterol; 1964; 10():87-90. PubMed ID: 14170208
    [No Abstract]   [Full Text] [Related]  

  • 3. [THERAPY OF PEPTIC ULCER WITH GEFARNATE, GERANYL FARNESYL ACETATE].
    GOUVEIA OF; GALPER E; DA CUNHA M; TEIXEIRA D
    Rev Bras Med; 1965 Feb; 22():85-94. PubMed ID: 14336325
    [No Abstract]   [Full Text] [Related]  

  • 4. [OUR EXPERIENCE WITH "GEFARNIL" IN THE PEPTIC ULCER].
    GONZALEZCAMPOS C; GUTIERREZGUTIERREZ L
    Rev Clin Esp; 1964 Dec; 95():377-84. PubMed ID: 14268082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of the effect of geranyl of farnesylacetate combined with nafiver in peptic ulcer patients].
    Mincis M
    Rev Bras Med; 1968 May; 25(5):324-7. PubMed ID: 5724217
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of 14C-labelled geranyl farnesylacetate (gefarnate).
    Coppi G; Bonardi G
    Arzneimittelforschung; 1969 Sep; 19(9):1518-9. PubMed ID: 5394524
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind trial of gefarnate and placebo in the treatment of gastric ulcer.
    Newcomb PB; Stone WD; Richardson PC; Smith PM; Gent A; Donovan B
    Practitioner; 1976 Sep; 217(1299):435-8. PubMed ID: 790358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the value of the product geranyl farnesyl acetate (Gefarnate) in the treatment of peptic ulcer].
    Nery AL; Nascif R
    Hospital (Rio J); 1966 Apr; 69(4):669-89. PubMed ID: 5295886
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of alprazolam, gefarnate and their combination in treatment of peptic ulcer patients--an application of life table analysis.
    Ogawa N; Namiki M; Kusunoki T; Fujii S
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):109-11. PubMed ID: 2859256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gefarnate.
    Drug Ther Bull; 1968 Nov; 6(24):94-5. PubMed ID: 5722353
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
    Fukuchi S
    Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
    [No Abstract]   [Full Text] [Related]  

  • 12. PHARMACOLOGICAL RESEARCH ON GEFARNATE, A NEW SYNTHETIC ISOPRENOID WITH AN ANTI-ULCER ACTION.
    ADAMI E; MARAZZI-UBERTI E; TURBA C
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():113-45. PubMed ID: 14116921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
    Sakai M
    Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
    [No Abstract]   [Full Text] [Related]  

  • 14. A double blind trial of carbenoxolone and geranyl farnesyl acetate in gastric ulcer.
    Smith PM; Sladen GE; Beck ER; Bennett PN; Lennard JE; Langman JS
    Scand J Gastroenterol; 1975; 10(7):753-5. PubMed ID: 1103273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic study of clinical trials of geranyl farnesylacetate].
    Da Grada CT; Greco O; Campagnoli P
    Minerva Gastroenterol; 1967; 13(4):157-64. PubMed ID: 5607546
    [No Abstract]   [Full Text] [Related]  

  • 16. A new screening method for anti-ulcer agents: psychological stress produced by intraspecies emotional communication.
    Ichimaru Y; Gomita Y
    Pharmacology; 1987; 34(2-3):176-80. PubMed ID: 3588656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gefarnate in the therapy of peptic ulcer].
    Ortone G; Furno F
    Minerva Med; 1968 Dec; 59(101):5647-62. PubMed ID: 5707471
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of gastric ulcer: a comparative trial of four preparations.
    Gutz HJ; Berndt H; Jackson D
    Practitioner; 1979 Jun; 222(1332):849-53. PubMed ID: 384388
    [No Abstract]   [Full Text] [Related]  

  • 19. An improved method for 14C-labelling of farnesylacetic acid and its geranyl ester.
    Nishioka K; Nakatsuka I; Kanamaru H
    Radioisotopes; 1988 Mar; 37(3):133-9. PubMed ID: 3387600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gefarnate (DA-688) in the treatment of peptic ulcer; immediate results].
    Lima JP; da Silveira TR; Kerz L
    Rev Bras Med; 1966 Mar; 23(3):193-8. PubMed ID: 5940586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.